| Year |
Citation |
Score |
| 2021 |
Bordone MP, Damianich A, Bernardi MA, Eidelman T, Sanz-Blasco S, Gershanik OS, Avale ME, Ferrario JE. Fyn knockdown prevents levodopa-induced dyskinesia in a mouse model of Parkinson's disease. Eneuro. PMID 34099487 DOI: 10.1523/ENEURO.0559-20.2021 |
0.754 |
|
| 2019 |
Bernardi A, Ballestero P, Schenk M, Ferrario M, Gómez G, Rivero R, Avale E, Taravini I, Gershanik O, Guerrero S, Ferrario JE. Yerba mate (Ilex paraguariensis) favors survival and growth of dopaminergic neurons in culture. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30938849 DOI: 10.1002/Mds.27667 |
0.619 |
|
| 2019 |
Cromberg LE, Saez TMM, Otero MG, Tomasella E, Alloatti M, Damianich A, Devoto VP, Ferrario J, Gelman D, Rubinstein M, Falzone TL. Neuronal KIF5b deletion induces striatum-dependent locomotor impairments and defects in membrane presentation of dopamine D2 receptors. Journal of Neurochemistry. PMID 30664247 DOI: 10.1111/Jnc.14665 |
0.606 |
|
| 2017 |
Gomez G, Saborido MD, Alejandra Bernardi M, Gershanik OS, Taravini IR, Ferrario JE. Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia. Neuroscience Letters. 666: 5-10. PMID 29241709 DOI: 10.1016/J.Neulet.2017.12.024 |
0.739 |
|
| 2017 |
Sanz-Blasco S, Bordone MP, Damianich A, Gomez G, Bernardi MA, Isaja L, Taravini IR, Hanger DP, Avale ME, Gershanik OS, Ferrario JE. The Kinase Fyn As a Novel Intermediate in L-DOPA-Induced Dyskinesia in Parkinson's Disease. Molecular Neurobiology. PMID 28840468 DOI: 10.1007/S12035-017-0748-3 |
0.723 |
|
| 2008 |
Ferrario JE, Rojas-Mayorquín AE, Saldaña-Ortega M, Salum C, Gomes MZ, Hunot S, Raisman-Vozari R. Pleiotrophin receptor RPTP-zeta/beta expression is up-regulated by L-DOPA in striatal medium spiny neurons of parkinsonian rats. Journal of Neurochemistry. 107: 443-52. PMID 18752647 DOI: 10.1111/j.1471-4159.2008.05640.x |
0.368 |
|
| 2008 |
Larramendy C, Taravini IR, Saborido MD, Ferrario JE, Murer MG, Gershanik OS. Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism. Behavioural Brain Research. 194: 44-51. PMID 18638507 DOI: 10.1016/J.Bbr.2008.06.021 |
0.682 |
|
| 2008 |
Salum C, Raisman-Vozari R, Michel PP, Gomes MZ, Mitkovski M, Ferrario JE, Ginestet L, Del Bel EA. Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons. Brain Research. 1198: 27-33. PMID 18255050 DOI: 10.1016/j.brainres.2007.12.054 |
0.359 |
|
| 2005 |
Taravini IR, Ferrario JE, Delbe J, Ginestet L, Debeir T, Courty J, Murer MG, Gershanik OS, Raisman-Vozari R. Immunodetection of heparin-binding growth associated molecule (pleiotrophin) in striatal interneurons. Brain Research. 1066: 196-200. PMID 16325783 DOI: 10.1016/J.Brainres.2005.10.055 |
0.8 |
|
| 2005 |
Mourlevat S, Debeir T, Ferrario JE, Delbe J, Caruelle D, Lejeune O, Depienne C, Courty J, Raisman-Vozari R, Ruberg M. Pleiotrophin mediates the neurotrophic effect of cyclic AMP on dopaminergic neurons: analysis of suppression-subtracted cDNA libraries and confirmation in vitro. Experimental Neurology. 194: 243-54. PMID 15899261 DOI: 10.1016/j.expneurol.2005.02.015 |
0.373 |
|
| 2004 |
Debeir T, Marien M, Ferrario J, Rizk P, Prigent A, Colpaert F, Raisman-Vozari R. In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration. Experimental Neurology. 190: 384-95. PMID 15530877 DOI: 10.1016/J.Expneurol.2004.08.023 |
0.407 |
|
| 2004 |
Ferrario JE, Taravini IR, Mourlevat S, Stefano A, Delfino MA, Raisman-Vozari R, Murer MG, Ruberg M, Gershanik O. Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system. Journal of Neurochemistry. 90: 1348-58. PMID 15341519 DOI: 10.1111/J.1471-4159.2004.02595.X |
0.767 |
|
| 2004 |
Delfino MA, Stefano AV, Ferrario JE, Taravini IR, Murer MG, Gershanik OS. Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias. Behavioural Brain Research. 152: 297-306. PMID 15196797 DOI: 10.1016/J.Bbr.2003.10.009 |
0.802 |
|
| 2003 |
Ferrario JE, Delfino MA, Stefano AV, Zbarsky V, Douhou A, Murer MG, Raisman-Vozari R, Gershanik OS. Effects of orally administered levodopa on mesencephalic dopaminergic neurons undergoing a degenerative process. Neuroscience Research. 47: 431-6. PMID 14630347 DOI: 10.1016/j.neures.2003.08.001 |
0.808 |
|
| 2001 |
Ferrario J, Murer MG, Raisman-Vozari R, Gershanik O. Chronic levodopa for Parkinson's disease: Beyond toxicity Focus On Parkinson's Disease. 13: 32-36. |
0.579 |
|
| 1999 |
Murer MG, Ferrario J, Delfino M, Dziewczapolski G, Gershanik OS, Raisman-Vozari R. Increased [125I]sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesions. Neuroreport. 10: 1501-5. PMID 10380970 |
0.697 |
|
| Show low-probability matches. |